Université Grenoble Alpes, CEA, CNRS, IBS , F-38000 Grenoble , France.
Département de Toxicologie et Risques Chimiques , Institut de Recherche Biomédicale des Armées , 91220 Brétigny-sur-Orge , France.
J Med Chem. 2018 Sep 13;61(17):7630-7639. doi: 10.1021/acs.jmedchem.8b00592. Epub 2018 Aug 31.
Acetylcholinesterase (AChE), a key enzyme in the central and peripheral nervous systems, is the principal target of organophosphorus nerve agents. Quaternary oximes can regenerate AChE activity by displacing the phosphyl group of the nerve agent from the active site, but they are poorly distributed in the central nervous system. A promising reactivator based on tetrahydroacridine linked to a nonquaternary oxime is also an undesired submicromolar reversible inhibitor of AChE. X-ray structures and molecular docking indicate that structural modification of the tetrahydroacridine might decrease inhibition without affecting reactivation. The chlorinated derivative was synthesized and, in line with the prediction, displayed a 10-fold decrease in inhibition but no significant decrease in reactivation efficiency. X-ray structures with the derivative rationalize this outcome. We thus show that rational design based on structural studies permits the refinement of new-generation pyridine aldoxime reactivators that may be more effective in the treatment of nerve agent intoxication.
乙酰胆碱酯酶(AChE)是中枢和外周神经系统中的关键酶,也是有机磷神经毒剂的主要靶标。季铵肟类化合物可以通过从活性部位置换神经毒剂的膦酰基来再生 AChE 活性,但它们在中枢神经系统中的分布较差。一种基于连接到非季铵肟的四氢吖啶的有前途的重活化剂也是 AChE 的非期望的亚微摩尔可逆抑制剂。X 射线结构和分子对接表明,四氢吖啶的结构修饰可能在不影响重活化的情况下降低抑制作用。合成了氯化衍生物,并且与预测一致,该衍生物的抑制作用降低了 10 倍,但重活化效率没有明显降低。与该衍生物的 X 射线结构解释了这一结果。因此,我们表明,基于结构研究的合理设计允许对新一代吡啶醛肟重活化剂进行改进,这可能更有效地治疗神经毒剂中毒。